Dna Damage Response In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The DNA damage response (DDR) is a critical cellular surveillance mechanism that maintains genomic integrity by detecting DNA lesions, activating repair pathways, and orchestrating cell cycle checkpoints. Key DNA repair proteins implicated in neurodegeneration include PRKDC (DNA-PKcs), XRCC6 (Ku70), XRCC5 (Ku80), and PARP1. In neurodegenerative diseases, progressive accumulation of DNA damage contributes to neuronal dysfunction and cell death. This pathway page explores the molecular mechanisms by which DNA damage accumulates in neurons, how impaired DNA repair promotes neurodegeneration, and therapeutic strategies targeting DDR components.
Neurons are particularly vulnerable to DNA damage due to their high metabolic activity, post-mitotic state, and exposure to reactive oxygen species. The major types of DNA damage affecting neurons include:
| Damage Type |
Source |
Repair Pathway |
Neurodegenerative Relevance |
| Oxidative lesions (8-oxoG) |
ROS from metabolism |
Base excision repair (BER) |
AD, PD, ALS |
| Single-strand breaks |
Oxidative stress, repair intermediates |
BER, SSB repair |
AD, PD |
| Double-strand breaks |
Radiation, oxidative stress, replication stress |
NHEJ, HR |
ALS, Ataxias |
| DNA base alkylation |
Endogenous metabolites |
Direct reversal, BER |
AD, Aging |
| Interstrand crosslinks |
Oxidative stress, environmental |
Fanconi anemia pathway |
ALS, Huntington's |
| Telomere shortening |
Replicative aging |
Telomerase, alternative lengthening |
Aging, AD |
flowchart TD
A[DNA Damage Sources] --> B{Detect Damage Type}
B -->|SSB/Base Damage| C[PARP1/2 Activation] -->
B -->|DSB| D[ATM/ATR Activation] -->
B -->|Alkylation| E[MGMT/ALKBH] -->
C --> F[DNA Repair Polymerases] -->
D --> G[MRN Complex] -->
E --> H[Direct Reversal] -->
F --> I[Ligase III/XRCC1] -->
G --> I
H --> J[Restored DNA] -->
I --> J
K[Chronic Damage] --> L[Persistent DDR Signaling] -->
L --> M[p53 Activation] -->
M --> N[Cell Cycle Arrest] -->
L --> O[PAR Polymer accumulation] -->
O --> P[Neuronal Dysfunction] -->
M --> Q[Apoptosis)
N --> R[Cellular Senescence)
P --> S[Neurodegeneration] -->
Q --> S
R --> S
PARP1/PARP2 (Poly ADP-ribose polymerases)
- Detect single-strand breaks and base damage
- Catalyze poly(ADP-ribosyl)ation of target proteins
- Recruit XRCC1/Ligase III for repair
- Overactivation leads to NAD+ depletion and cell death
- PARP inhibitors show promise in PD and ALS models
ATM (Ataxia Telangiectasia Mutated)
- Primary sensor for double-strand breaks
- Phosphorylates p53, CHK2, H2AX
- Activates cell cycle checkpoints
- ATM deficiency causes ataxia-telangiectasia with neurodegeneration
ATR (ATM and Rad3-Related)
- Responds to replication stress and single-strand breaks
- Activates CHK1 and S-phase checkpoint
- Important for neuronal survival under stress
| Pathway |
Substrates |
Key Proteins |
Neuronal Role |
| Base excision repair (BER) |
Oxidative damage, alkylation |
OGG1, NTH1, PARP1, Pol β, Lig III |
Critical for removing 8-oxoG and ROS damage |
| Nucleotide excision repair (NER) |
UV damage, bulky adducts |
XPA-G, TFIIH, ERCC1 |
Repair of transcription-blocking lesions |
| Mismatch repair (MMR) |
Replication errors |
MSH2/6, MLH1, PMS2 |
Implicated in triplet repeat expansion |
| Non-homologous end joining (NHEJ) |
DSB |
Ku70/80, DNA-PKcs, Ligase IV |
Primary DSB repair in neurons |
| Homologous recombination (HR) |
DSB in S/G2 |
RAD51, BRCA1/2, PALB2 |
Limited in post-mitotic neurons |
| Direct reversal |
Alkylation |
MGMT, ALKBH2/3 |
Quick repair of specific damage |
In AD, DNA damage accumulates through multiple mechanisms:
- Amyloid-β induced damage: Aβ oligomers increase ROS production, causing oxidative DNA damage
- Tau pathology: Hyperphosphorylated tau impairs DNA repair by sequestering DNA-PK
- Mitochondrial dysfunction: mtDNA mutations accumulate in AD neurons
- Impaired BER: Reduced OGG1 activity leads to 8-oxoG accumulation
- Telomere shortening: Accelerated telomere attrition in AD patients
Key findings:
- Elevated 8-oxoG levels in AD brain (3-5 fold increase)
- Reduced PARP1 activity in AD neurons (paradoxical - can indicate exhaustion)
- Increased p53 and p21 expression in vulnerable neurons
- DNA-PKcs activity reduced in AD hippocampus
DNA damage in PD is linked to:
- Dopamine oxidation: Auto-oxidation of dopamine generates reactive oxygen species
- Mitochondrial Complex I deficiency: Leads to ROS production and mtDNA damage
- α-Synuclein toxicity: Can directly interact with DNA and impair repair
- LRRK2 mutations: Affect DNA damage response signaling
- GBA1 deficiency: Leads to increased oxidative stress and DNA damage
Key findings:
- Increased γH2AX foci in PD substantia nigra neurons
- Reduced OGG1 and PARP1 activity
- Accumulation of mtDNA deletions in dopaminergic neurons
- Enhanced sensitivity to genotoxic stress in LRRK2 mutant models
DNA damage accumulation in ALS:
- C9orf72 expansions: RNA foci and dipeptide repeats cause R-loop formation
- SOD1 mutations: Produce ROS, causing oxidative DNA damage
- TDP-43 pathology: Impairs transcription and DNA repair gene expression
- FUS mutations: Disrupt DNA damage response
- Chronic DDR activation: Leads to p53-mediated apoptosis
Key findings:
- Elevated DNA damage markers in ALS motor neurons
- Reduced DNA repair capacity (BER, NER)
- TDP-43 mislocalization impairs DDR signaling
- C9orf72 patient-derived neurons show increased DNA damage
DNA damage in HD:
- Mutant huntingtin: Directly binds DNA and impairs repair complexes
- Transcriptional dysfunction: Leads to DNA replication stress
- Mitochondrial dysfunction: Causes oxidative DNA damage
- Triplet repeat instability: Expands in neurons over time
| Strategy |
Target |
Compound/Approach |
Status |
| PARP inhibition |
PARP1/2 |
Olaparib, rucaparib |
Preclinical AD/PD |
| p53 modulation |
p53 |
Pifithrin-α |
Preclinical |
| BER enhancement |
Pol β, Lig III |
Gene therapy approaches |
Research |
| NER enhancement |
XPA, TFIIH |
Small molecule activators |
Research |
| Telomerase activation |
Telomerase |
TA-65, gene therapy |
Aging research |
- Mitochondrial antioxidants: CoQ10, MitoQ target mtDNA damage
- NAC and glutathione: Boost cellular antioxidant capacity
- Metal chelation: Deferoxamine reduces iron-induced damage
- OGG1 delivery: Adenoviral OGG1 to enhance 8-oxoG repair
- PARP1 modulation: AAV-delivered PARP inhibitors
- Ataxia-telangiectasia: ATM gene therapy in development
| Biomarker |
Detection |
Disease |
Utility |
| 8-oxoG in CSF |
ELISA, mass spec |
AD, PD |
Diagnostic |
| γH2AX foci |
Immunohistochemistry |
ALS, PD |
Research |
| Tail moment (Comet assay) |
Single cell gel electrophoresis |
All |
Research |
| p53 phosphorylation |
Western blot |
AD, PD |
Prognostic |
| ATM activation |
Immunohistochemistry |
Ataxias |
Diagnostic |
The DNA damage response intersects with multiple neurodegenerative pathways:
- Mitochondrial dysfunction: Bidirectional - mtDNA damage causes dysfunction, and mitochondrial dysfunction produces ROS that damage nuclear DNA
- Oxidative stress pathway: Primary source of endogenous DNA damage
- Neuroinflammation: Chronic inflammation produces ROS and RNS that damage DNA
- Cellular senescence: Persistent DDR contributes to senescence-associated secretory phenotype (SASP)
- Protein quality control: DNA damage can trigger the unfolded protein response
The study of Dna Damage Response In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- DNA damage and repair in Alzheimer's disease
- DNA damage in Parkinson's disease: mechanisms and therapeutic opportunities
- DNA damage response in amyotrophic lateral sclerosis
- PARP inhibition in neurodegenerative diseases
- Oxidative DNA damage and repair in the aging brain
- C9orf72 hexanucleotide repeat expansion causes DNA damage response defects
- Tau pathology impairs DNA damage repair
- Mitochondrial DNA damage in neurodegenerative diseases
- Lindahl T, Barnes DE. (2000). "Repair of endogenous DNA damage." Cold Spring Harb Symp Quant Biol 65: 127-133. PMID:12769727
- Krokan HE, Bjørås M. (2013). "Base excision repair." Cold Spring Harb Perspect Biol 5(4): a012583. PMID:23545175
- Hegde ML, et al. (2013). "Emerging links between base excision DNA repair deficiency and neurodegenerative diseases." DNA Repair 17: 55-73. PMID:24704612
- Weissman L, et al. (2007). "DNA damage, mitochondrial dysfunction, and synaptic deficits in the hippocampus of aged mice." J Bioenerg Biomembr 39(1): 73-82. PMID:17354034
- Coppedè F, et al. (2014). "The role of mutations in DNA repair genes in amyotrophic lateral sclerosis." Pharmacogenomics 15(9): 1205-1214. PMID:25155900
- Martin LJ, et al. (2015). "DNA oxidation in Alzheimer's disease and ALS." Brain Res 1628: 273-282. PMID:26048472
- Kim J, et al. (2017). "MUTYH-associated Parkinson's disease." J Neural Transm 124(10): 1177-1184. PMID:28589579
- Katyal S, et al. (2014). "DNA damage and neurodegeneration." Ageing Res Rev 18: 3-14. PMID:25219766
- Jęśko H, et al. (2020). "DNA damage and repair in neurodegenerative diseases." Neural Regen Res 15(2): 255-262. PMID:31531664
- Chen D, et al. (2019). "PARP inhibition: a promising therapeutic target in ALS." Neuropharmacology 145: 1-10. PMID:30465735
🔴 Low Confidence
| Dimension |
Score |
| Supporting Studies |
8 references |
| Replication |
33% |
| Effect Sizes |
25% |
| Contradicting Evidence |
0% |
| Mechanistic Completeness |
50% |
Overall Confidence: 34%